KRAS inhibitor program, Redx Transaction


Listed Equity Investment Deal in United Kingdom, Europe

Transaction Details

Name:KRAS inhibitor program, Redx
Amount:Available on swfi.com
Announced At:02/07/2024
Closed At:02/07/2024
RegionEurope
Country:United Kingdom
Type:Deal
Security Type:Ordinary Shares
Investment Type:Listed Equity
SectorHealthcare
Industry:Pharmaceuticals
Summary:Available

Buyers

Entity 1
Pharmaceutical Company in Ireland
Stake
Available on swfi.com

Sellers

Entity 1
Company in United Kingdom
Stake
Available on swfi.com